Kristine A. Frerichs
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective.
Journal: Frontiers in immunology
Published: December 16, 2025
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels.
Journal: HemaSphere
Published: March 17, 2025
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 30, 2023
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
Journal: Blood advances
Published: September 11, 2023
Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity.
Journal: EBioMedicine
Published: December 12, 2022
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.
Journal: Science translational medicine
Published: December 08, 2021
Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.
Journal: Journal of clinical medicine
Published: August 30, 2021
Last Updated: 09/26/2026